Our mission:  To develop new therapies for type 1 and type 2 diabetes

Fairbanks Pharmaceuticals is developing transformative diabetes therapies that address the underlying cause of diabetes: loss of insulin from beta cells.


Learn about Fairbanks Pharmaceuticals

Fairbanks Pharmaceuticals CEO Alan Schneyer
Fairbanks CEO Alan Schneyer with Lab and Animal Technician Alexa Lopez
Fairbanks Pharmaceuticals CEO Alan Schneyer
Fairbanks CEO Alan Schneyer with Technician Intern Alyssa Berthelette